References
- Reeves RR, Carter OS, Pinkofsky HB, et al. Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis. 1999;18:51–56.
- Littrell RA, Hayes LR, Stillner V. Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J. 1993;86:753–756.
- Morse RM, Chua L. Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse. 1978;5:527–530.
- Iorio DD, Henley E, Doughty AA. A survey of primary care physician practice patterns and adherence to acute low back problem guidelines. Arch Fam Med. 2000;9:1015–1021.
- Bramness JG, Department of Pharmacoepidemiology DoE, Norwegian Institute of Public Health, Oslo, Furu K, et al. Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. Br J Clin Pharmacol. 2017;64:210–218.
- Sikdar S, Basu D, Malhotra AK, et al. Carisoprodol abuse: a report from India. Acta Psychiatr Scand. 2017;88:302–303.
- Pattanayak RD, Ambekar A, Chatterjee B, et al. Substitution of alcohol with carisoprodol: a case for concern. Indian J Med Sci. 2017;69:55–56.
- Nebhinani N, Aggarwal M, Mattoo SK, et al. Carisoprodol: an under recognized drug of abuse in north India. GenHospPsych. 2013;35:89–92.
- Reeves RR, Beddingfield JJ, Mack JE. Carisoprodol withdrawal syndrome. Pharmacotherapy. 2004;24:1804–1806.
- Høiseth G, Sørlid HK, Bramness J. Acute intoxications with carisoprodol. Clin Toxicol. 2008;46:307–309.
- Fass JA. Carisoprodol legal status and patterns of abuse. Ann Pharmacother. 2010;44:1962–1967.
- Spiller HA, Scaglione JM, et al. Effect of scheduling tramadol as a controlled substance on poison center exposures to tramadol. Ann Pharmacother. 2010;44:1016–1021.
- Høiseth G, Karinen R, et al. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug. Basic Clin Pharmacol Toxicol. 2009;105:345–349.
- Kantor ED, Rehm CD, Haas JS, et al. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;313:1818–1831.
- Lessenger JE, Feinberg SD. Abuse of prescription and over-the-counter medications. J Am Board Fam Med. 2008;21:45–54.
- Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: ED Visits Involving the Muscle Relaxant Carisoprodol; [cited 2015 July 25]. Available from: http://oas.samhsa.gov/2k11/DAWN071/WEB_DAWN_071_HTML.pdf.
- Pugh MJ, Hanlon JT, Wang CP, et al. Trends in use of high-risk medications for older veterans: 2004 to 2006. J Am Geriatr Soc. 2011;59:1891–1898.
- Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68:936–947.
- Turner L, Krusewski SP, Alexander GC. Trends in the use of buprenorphine by office-based physicians in the United States, 2003–2013. Am J Addict. 2015;24:24–29.
- Haynes A, Kleinschmidt K, Forrester MB, et al. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone. Clin Toxicol. 2016;54:434–440.